Similarly, the proportion of CD11c-expressing MAMs was approximately 2-fold higher in dural versus parenchymal metastases and this difference was significant across all 3 cancer models (Figure 2D–2E, Supplementary Figure S4B, Supplementary Figure S5A–S5B). This evidence concerns the gene ITGAX and cancer.